Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202235295> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3202235295 endingPage "132" @default.
- W3202235295 startingPage "132" @default.
- W3202235295 abstract "Objective: In this study, we intended to evaluate the effectiveness and safety of switching to lurasidone in patients with schizophrenia and to get clinical experiences of real-world practice in those who showed suboptimal therapeutic effect and/or intolerability to lurasidone in Taiwan. Methods: We enrolled adult patients (aged 20–75 years) with schizophrenia who had been receiving antipsychotic medications but still continued to show mild-to-moderate symptoms or intolerability, for switching switch to an open-label lurasidone 40–160 mg daily for six weeks. The primary end point of the study was to assess the time to treatment failure, defined as any occurrence of insufficient clinical response, worsen underlying symptoms, or discontinuation due to adverse events. Secondary efficacy measures of the study included decreased scores in the positive and negative syndrome scale (PANSS) total and the clinical global impression-severity scale.(CGI-S), as well as increased clinical global impression-improvement scale (CGI-I). Safety measures included occurrences of treatment-emergent adverse events (TEAEs), abnormal vital signs, Electrocardiogram (ECG), and laboratory parameters. Results: We enrolled 54 patients with 51 completing the study. One patient terminated early due to adverse events and two patients had insufficient therapeutic efficacy. Mean ± standard deviation (SD) time to treatment failure was 27.7 ± 13.1 days. Mean ± SD changes from baseline to six weeks on PANSS, CGI-S, and were −16.8 ± 14.4, −0.6 ± 0.59, and −1.1 ± 1.0, respectively . The most common TEAE was hyperprolactinemia. Furthermore, body weight was significantly decreased from baseline to the end of the study by 0.83 ± 1.96 kg (p" @default.
- W3202235295 created "2021-10-11" @default.
- W3202235295 creator A5046538397 @default.
- W3202235295 creator A5068813241 @default.
- W3202235295 creator A5073149170 @default.
- W3202235295 date "2021-01-01" @default.
- W3202235295 modified "2023-09-26" @default.
- W3202235295 title "Lurasidone switching in patients with schizophrenia who showed suboptimal effect and/or intolerability to current antipsychotics: A multi-center, open-label, single-arm, flexible dose study" @default.
- W3202235295 doi "https://doi.org/10.4103/tpsy.tpsy_26_21" @default.
- W3202235295 hasPublicationYear "2021" @default.
- W3202235295 type Work @default.
- W3202235295 sameAs 3202235295 @default.
- W3202235295 citedByCount "0" @default.
- W3202235295 crossrefType "journal-article" @default.
- W3202235295 hasAuthorship W3202235295A5046538397 @default.
- W3202235295 hasAuthorship W3202235295A5068813241 @default.
- W3202235295 hasAuthorship W3202235295A5073149170 @default.
- W3202235295 hasBestOaLocation W32022352951 @default.
- W3202235295 hasConcept C118552586 @default.
- W3202235295 hasConcept C126322002 @default.
- W3202235295 hasConcept C142724271 @default.
- W3202235295 hasConcept C197934379 @default.
- W3202235295 hasConcept C204787440 @default.
- W3202235295 hasConcept C27081682 @default.
- W3202235295 hasConcept C2776000289 @default.
- W3202235295 hasConcept C2776412080 @default.
- W3202235295 hasConcept C2776701107 @default.
- W3202235295 hasConcept C2778715236 @default.
- W3202235295 hasConcept C2779727114 @default.
- W3202235295 hasConcept C2780135775 @default.
- W3202235295 hasConcept C2780494398 @default.
- W3202235295 hasConcept C71924100 @default.
- W3202235295 hasConceptScore W3202235295C118552586 @default.
- W3202235295 hasConceptScore W3202235295C126322002 @default.
- W3202235295 hasConceptScore W3202235295C142724271 @default.
- W3202235295 hasConceptScore W3202235295C197934379 @default.
- W3202235295 hasConceptScore W3202235295C204787440 @default.
- W3202235295 hasConceptScore W3202235295C27081682 @default.
- W3202235295 hasConceptScore W3202235295C2776000289 @default.
- W3202235295 hasConceptScore W3202235295C2776412080 @default.
- W3202235295 hasConceptScore W3202235295C2776701107 @default.
- W3202235295 hasConceptScore W3202235295C2778715236 @default.
- W3202235295 hasConceptScore W3202235295C2779727114 @default.
- W3202235295 hasConceptScore W3202235295C2780135775 @default.
- W3202235295 hasConceptScore W3202235295C2780494398 @default.
- W3202235295 hasConceptScore W3202235295C71924100 @default.
- W3202235295 hasIssue "3" @default.
- W3202235295 hasLocation W32022352951 @default.
- W3202235295 hasOpenAccess W3202235295 @default.
- W3202235295 hasPrimaryLocation W32022352951 @default.
- W3202235295 hasRelatedWork W11970049 @default.
- W3202235295 hasRelatedWork W14942699 @default.
- W3202235295 hasRelatedWork W1742370 @default.
- W3202235295 hasRelatedWork W17659181 @default.
- W3202235295 hasRelatedWork W17747543 @default.
- W3202235295 hasRelatedWork W20076629 @default.
- W3202235295 hasRelatedWork W3309157 @default.
- W3202235295 hasRelatedWork W5032858 @default.
- W3202235295 hasRelatedWork W8546129 @default.
- W3202235295 hasRelatedWork W9412413 @default.
- W3202235295 hasVolume "35" @default.
- W3202235295 isParatext "false" @default.
- W3202235295 isRetracted "false" @default.
- W3202235295 magId "3202235295" @default.
- W3202235295 workType "article" @default.